These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10465355)

  • 21. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase.
    Zingarelli B; Cuzzocrea S; Zsengellér Z; Salzman AL; Szabó C
    Cardiovasc Res; 1997 Nov; 36(2):205-15. PubMed ID: 9463632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain.
    Ducrocq S; Benjelloun N; Plotkine M; Ben-Ari Y; Charriaut-Marlangue C
    J Neurochem; 2000 Jun; 74(6):2504-11. PubMed ID: 10820212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation.
    Pulido EJ; Shames BD; Selzman CH; Barton HA; Banerjee A; Bensard DD; McIntyre RC
    Am J Physiol; 1999 Oct; 277(4):L769-76. PubMed ID: 10516218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(Adp-ribose) synthetase inhibition prevents lipopolysaccharide-induced peroxynitrite mediated damage in diaphragm.
    Ozdülger A; Cinel I; Unlü A; Cinel L; Mavioglu I; Tamer L; Atik U; Oral U
    Pharmacol Res; 2002 Jul; 46(1):67-73. PubMed ID: 12208123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxynitrite-mediated DNA strand breakage activates poly (ADP-ribose) synthetase and causes cellular energy depletion in carrageenan-induced pleurisy.
    Cuzzocrea S; Caputi AP; Zingarelli B
    Immunology; 1998 Jan; 93(1):96-101. PubMed ID: 9536124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of inhibitors of poly(ADP-ribose) synthetase activity on hypotension and multiple organ dysfunction caused by endotoxin.
    Wray GM; Hinds CJ; Thiemermann C
    Shock; 1998 Jul; 10(1):13-9. PubMed ID: 9688085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia.
    Liaudet L; Szabó A; Soriano FG; Zingarelli B; Szabó C; Salzman AL
    Shock; 2000 Aug; 14(2):134-41. PubMed ID: 10947156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
    Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
    Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity.
    Cuzzocrea S; Zingarelli B; Gilad E; Hake P; Salzman AL; Szabó C
    J Pineal Res; 1997 Sep; 23(2):106-16. PubMed ID: 9392449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of poly(ADP-ribose)synthetase in inflammation.
    Szabó C
    Eur J Pharmacol; 1998 May; 350(1):1-19. PubMed ID: 9683009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Maffia P; Patel NS; Di Paola R; Ialenti A; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Eur J Pharmacol; 2004 Jan; 483(1):79-93. PubMed ID: 14709329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the activation of poly (ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture?
    Baechtold F; Scott JA; Markert M; Mehta S; McCormack DG; Anglada F; Galaud D; Vaglio M; Waeber B; Feihl F
    Shock; 2001 Aug; 16(2):137-42. PubMed ID: 11508866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress.
    Chatterjee PK; Cuzzocrea S; Thiemermann C
    Kidney Int; 1999 Sep; 56(3):973-84. PubMed ID: 10469365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat.
    Besson VC; Croci N; Boulu RG; Plotkine M; Marchand-Verrecchia C
    Brain Res; 2003 Oct; 989(1):58-66. PubMed ID: 14519512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo.
    Chatterjee PK; Zacharowski K; Cuzzocrea S; Otto M; Thiemermann C
    FASEB J; 2000 Apr; 14(5):641-51. PubMed ID: 10744621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.
    Gupta S; Kaul CL; Sharma SS
    Neurol Res; 2004 Jan; 26(1):103-7. PubMed ID: 14977067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
    Mabley JG; Suarez-Pinzon WL; Haskó G; Salzman AL; Rabinovitch A; Kun E; Szabó C
    Br J Pharmacol; 2001 Jul; 133(6):909-19. PubMed ID: 11454665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats.
    Lescot T; Fulla-Oller L; Palmier B; Po C; Beziaud T; Puybasset L; Plotkine M; Gillet B; Meric P; Marchand-Leroux C
    J Neurotrauma; 2010 Jun; 27(6):1069-79. PubMed ID: 20380552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PARP inhibition reduces acute colonic inflammation in rats.
    Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C
    Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of melatonin on zymosan-induced cellular damage.
    Cuzzocrea S; Caputi AP
    Biol Signals Recept; 1999; 8(1-2):136-42. PubMed ID: 10085476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.